akebia therapeutics buyout：After FDA snub
After FDA snub
2023年2月27日—AfterbeingrejectedbytheFDA,AkebiaTherapeuticsanditsoralanemiadrughavefoundsolaceinEurope.。其他文章還包含有：「AkebiaTherapeuticsandKeryxBiopharmaceuticals...」、「AkebiaTherapeuticsandKeryxBiopharmaceuticalsmerge...」、「AkebiaTherapeuticsandKeryxBiopharmaceuticalsto...」、「AkebiaTherapeuticstomergewithKeryxBiopharmaceuticals」、「AkebiaTherapeutics」、「Akebia」、「Akebia」、...
查看更多 離開網站
Akebia Therapeutics and Keryx Biopharmaceuticals ...
https://ir.akebia.com
Akebia Therapeutics, Inc. (Nasdaq:AKBA) and ; Keryx Biopharmaceuticals, Inc. today announced the successful completion of their previously announced merger.
Akebia Therapeutics and Keryx Biopharmaceuticals merge ...
https://healthcare-digital.com
Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company ... Akebia Therapeutics, Inc and Keryx Biopharmaceuticals have ...
Akebia Therapeutics and Keryx Biopharmaceuticals to ...
https://www.businesswire.com
The transaction will create a fully integrated biopharmaceutical company focused on chronic kidney disease (CKD), with an implied pro forma ...
Akebia Therapeutics to merge with Keryx Biopharmaceuticals
https://www.pharmaceutical-tec
US-based biopharmaceutical firm Akebia Therapeutics has signed a definitive agreement to merge with Keryx Biopharmaceuticals to form a fully ...
Akebia Therapeutics
https://seekingalpha.com
Akebia Therapeutics Inc. is rated a Strong Buy due to its overly discounted revenue and strong prospects in the large Chronic Kidney Disease ...
Akebia
https://www.biopharmadive.com
Kidney disease specialist Akebia Therapeutics will merge with Boston-based Keryx Biopharmaceuticals in an all-stock deal, creating a $1 ...
Akebia
https://www.fiercebiotech.com
Akebia Therapeutics is set to merge with Keryx Biopharmaceuticals. The combined company will own potentially complementary kidney disease ...
Robbins LLP Announces that Akebia Therapeutics
https://www.businesswire.com
SHAREHOLDER ALERT: Robbins LLP Announces that Akebia Therapeutics, Inc. (AKBA) is Being Sued for Misleading Keryx Biopharmaceuticals, ...